Search

everythinglearnresearchcommunity

for

Search:↓

Endocrine therapies for cancer significantly increase the risk of hair loss.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Epidermolysis bullosa is an inherited condition causing fragile skin with no cure, managed by wound care and experimental treatments show promise.

Effective management of children's hair loss involves accurate diagnosis, various treatments, and supportive care.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

Toxic epidermal necrolysis is a severe skin reaction often linked to drugs, requiring careful medication use and supportive care.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Hair loss treatments show limited improvement, sunscreen thickness affects vitamin D production, and the effectiveness of IVIg for toxic epidermal necrolysis is uncertain.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

Children under 18 had milder SARS with no deaths, but teenagers faced higher severe illness risk, and effective treatments were uncertain.

Alopecia Areata is a hair loss condition affecting all genders, often linked to other diseases, with treatments available but varying success rates.

Some drugs can cause rare but potentially deadly skin reactions, and early treatment and avoiding the drug again are key.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

The document concludes that early diagnosis and a comprehensive treatment plan are crucial for managing hair loss in children, with a focus on both medical and psychological support.

Alopecia areata is unpredictable, with limited treatment effectiveness, especially in severe cases.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

A girl with a rare genetic disorder had a unique bone condition, highlighting the need for careful diagnosis and suggesting the disorder might be more common than thought.

People undergoing chemotherapy need better support and information to cope with hair loss.

Combining letrozole with metformin is the most effective treatment for inducing pregnancy in women with PCOS.

Puerto Rican children with cancer often experience symptoms like irritability, nausea, and hair loss, and need better education and continuous symptom management.

Mange in rabbits is a serious disease that can spread to humans and is treated with medications and supportive care.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

The convention discussed various skin conditions, treatments, and the importance of continuous learning in dermatology nursing.

Palliative chemotherapy is cost-effective for advanced gastric and colorectal cancer but not clearly for pancreatic-biliary cancer.

Skin reactions to drugs are common and can be deadly, usually requiring stopping the drug and may be better prevented with genetic testing in the future.